Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Highly effective antinephritic agent derived from linomide

Feb. 1, 2002

Preparation and use of new series of PDE5 inhibitors

Jan. 29, 2002

Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis

Jan. 29, 2002

Vivus cleared to proceed with TA-1790 trial in erectile dysfunction

Jan. 22, 2002

Research snapshots in sexual dysfunction

Jan. 22, 2002

Selective alpha1A-adrenoceptor antagonists claimed for therapy of BPH

Jan. 15, 2002

Ortho-McNeil claims series of PDE5 inhibitors and use in sexual dysfunction

Jan. 11, 2002

Oxadiazole MMP inhibitors reported useful for renal diseases in Shionogi patent

Jan. 8, 2002

IND approval for NicOx's HCT-1026 for urinary incontinence

Jan. 8, 2002

Tamsulosin may provide effective treatment for reboxetine-associated urinary hesitancy

Jan. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...